AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts
Rhea-AI Summary
AI/ML Innovations (OTC:AIMLF) has engaged Guerilla Capital to provide investor relations, communications, and investor outreach services.
The engagement starts immediately for an initial term of 12 months at an aggregate fee of Cdn$120,000. Cdn$30,000 is payable up front and the remaining Cdn$90,000 is payable in three quarterly installments of Cdn$30,000. The agreement may be terminated any time after the initial three months.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, AIMLF declined 4.51%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers in Health Information Services show mixed, mostly flat moves: one notable mover is CRVW up 4.33%, while DGNMF is down 0.95% and others are unchanged, suggesting AIMLF’s setup is more stock-specific than broad sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 09 | Commercial term sheet | Positive | -4.0% | Non-binding term sheet to integrate MaxYield and Insight360 into wellness platform. |
| Dec 02 | Pilot collaboration | Positive | -7.7% | Pilot with Cornerstone Physiotherapy for elite athlete cardiac performance testing. |
| Nov 26 | Commercial term sheet | Positive | +21.1% | Equimetrics term sheet to deploy MaxYield and CardioYield across equine platforms. |
| Nov 11 | Patent allowance | Positive | -4.7% | U.S. patent allowance protecting core ECG signal-processing architecture. |
| Nov 04 | Regulatory engagement | Positive | -0.8% | Engagement of consultants for CardioYield submission in Jamaica plus stock option grant. |
Recent seemingly positive commercial and IP updates have often been met with flat-to-negative price reactions, with only one strong positive move on a commercial term sheet.
Over the last month, AIML has issued several commercialization and IP updates. NeuralCloud signed commercial term sheets with Equimetrics and Culminate H Labs and entered a pilot with Cornerstone Physiotherapy, while also engaging Lonacas Consultants for a CardioYield™ regulatory submission and securing a U.S. patent on its core ECG architecture. Price reactions ranged from -7.69% to +21.05%, showing mixed alignment between positive news flow and market response.
Market Pulse Summary
This announcement outlines a 12‑month, Cdn$120,000 investor relations engagement aimed at strengthening communications and outreach. Placed against a backdrop of multiple recent commercial and regulatory milestones with mixed price reactions, the move signals a focus on better translating the story to the market rather than changing fundamentals. Investors may watch how future news dissemination, clarity of messaging, and trading liquidity evolve following this IR partnership.
AI-generated analysis. Not financial advice.
TORONTO, ON / ACCESS Newswire / December 11, 2025 / AI/ML Innovations Inc. (CSE:AIML) ("AIML" or the "Company") is pleased to announce the engagement of Guerilla Capital ("Guerilla"), an arm's length investor relations firm with offices in Ontario, Canada. Guerilla will provide investor relations services to the Company including enhancing the Company's communications and investor outreach efforts.
The initial term of the engagement will commence immediately and continue for a period of 12 months (subject to extension) at an aggregate fee of Cdn
Guerilla may be contacted at:
2855322 ONTARIO INC. O/A GUERILLA CAPITAL
84 Watson' Lane, Dundas, Ontario, L9H 1T3
Email: Ryan@guerillacapital.io
Telephone: 416-832-1874
About AI/ML Innovations Inc.
AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.
AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis (778) 405-0882
On behalf of the Board of Directors:
Paul Duffy, Executive Chairman and CEO
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including risks associated with the implementation of the Company's products and services. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including with respect to the nature and timing of future operations and the receipt of all applicable regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
What did AI/ML Innovations (AIMLF) announce on December 11, 2025 about investor relations?
How much will AI/ML Innovations (AIMLF) pay Guerilla Capital for the 12-month engagement?
When can AI/ML Innovations (AIMLF) terminate the Guerilla Capital engagement?
What services will Guerilla Capital provide to AI/ML Innovations (AIMLF)?
How can investors contact Guerilla Capital regarding AIMLF's engagement?
